| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/12/2013 | EP2602255A1 Fused heterocyclic ring compound |
| 06/12/2013 | EP2602254A1 Heterocyclic compound |
| 06/12/2013 | EP2602253A1 Crystal of anti-bacterial compound |
| 06/12/2013 | EP2602252A1 Pyridazine derivatives and use thereof as medicaments for treating microrna viral infection |
| 06/12/2013 | EP2602248A1 Novel pyrrole compounds |
| 06/12/2013 | EP2601186A2 4-(1h-indol-3-yl)-pyrimidines as alk inhibitors |
| 06/12/2013 | EP2601185A1 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents |
| 06/12/2013 | EP2601174A1 Substituted indole and azaindole oxoacetyl piperazinamide derivatives |
| 06/12/2013 | EP2600874A1 Pyrimidine compounds that inhibit anaplastic lymphoma kinase |
| 06/12/2013 | EP2600860A1 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat proteins |
| 06/12/2013 | CN1921885B Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient |
| 06/12/2013 | CN103153985A Sterically hindered amine light stabilizers with mixed functionalization |
| 06/12/2013 | CN103153984A Inhibitors of bruton's tyrosine kinase |
| 06/12/2013 | CN103153983A Crystalline (r) - (e) -2- (4- (2- (5- (1- (3, 5 -dichloropyridin-4 -yl) ethoxy) - 1H - indazol - 3 - yl) vinyl) -1 H- pyrazol- 1 -yl) ethanol and its use as FGFR inhibitor |
| 06/12/2013 | CN103153982A 4-(1H-Indol-3-yl) -pyrimidines as ALK inhibitors |
| 06/12/2013 | CN103153981A New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl] -phenyl} - cyclohexyl) -acetic acid |
| 06/12/2013 | CN103153980A Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents |
| 06/12/2013 | CN103153968A Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
| 06/12/2013 | CN103153963A Cyclopropane compound |
| 06/12/2013 | CN103153962A Fungicidal imidazoles |
| 06/12/2013 | CN103153958A Novel microbiocidal dioxime ether derivatives |
| 06/12/2013 | CN103153957A N-pyridin-3-yl or N-pyrazin-2-yl carboxamides |
| 06/12/2013 | CN103153955A Pyridine compounds and the uses thereof |
| 06/12/2013 | CN103153951A Pyrrolidinones as MetAP-2 inhibitors |
| 06/12/2013 | CN103153950A Serotonin reuptake inhibitors |
| 06/12/2013 | CN103153949A Insecticidal pyrrolidin-yl-aryl-carboxamides |
| 06/12/2013 | CN103145702A Aminopyrimidines useful as kinase inhibitors |
| 06/12/2013 | CN103145696A Organic ligand and metal organic frame based on Cu(II) ion, as well as synthesis method and application thereof |
| 06/12/2013 | CN103145695A Novel technology for preparing fasudil hydrochloride |
| 06/12/2013 | CN103145694A Crystal R of sodium esomeprazole, preparation method and purpose thereof |
| 06/12/2013 | CN103145693A Preparation method of imatinib |
| 06/12/2013 | CN103145631A Antibacterial derivative of quinoxaline-1,4-dioxide and application in animal production thereof |
| 06/12/2013 | CN103145616A Novel nitrogen-containing heteroaryl compounds and methods of use thereof |
| 06/12/2013 | CN102382105B Bipolar host material used for blue emitting phosphor |
| 06/12/2013 | CN102367249B More stable pantoprazole compound and its pharmaceutical composition |
| 06/12/2013 | CN102276581B N-substituted tetrahydropyridine bound indole compound as well as preparation method and application thereof |
| 06/12/2013 | CN102105458B 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as NK1 receptor antagonists |
| 06/12/2013 | CN102093339B Preparation method and application of pyrimidine derivatives |
| 06/12/2013 | CN101970424B Indolyl- pyridone derivatives having checkpoint kinase 1 inhibitory activity |
| 06/12/2013 | CN101932562B Carbamoyl compounds as dgat1 inhibitors 190 |
| 06/12/2013 | CN101671291B Organic electroluminescent compounds and organic electroluminescent device using the same |
| 06/12/2013 | CN101490040B 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial |
| 06/12/2013 | CN101490037B Biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same |
| 06/12/2013 | CN101273013B Sulfonamide derivative having PGD2 receptor antagonistic activity |
| 06/12/2013 | CN101258138B Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3-receptor ligands |
| 06/12/2013 | CN101208311B Pyrazine -2-carboxamide derivatives as mglur5 antagonists |
| 06/11/2013 | US8461338 (1R, 1′R)-atracurium salts separation process |
| 06/11/2013 | US8461329 Isoquinoline derivative |
| 06/11/2013 | US8461183 PPAR agonist compounds, preparation and uses |
| 06/11/2013 | US8461160 Dihydropyrimidinones |
| 06/11/2013 | CA2730511C 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 06/11/2013 | CA2722102C Phenylpropionic acid derivative and use thereof |
| 06/11/2013 | CA2601870C Conversion of 2-pyrazolines to pyrazoles using bromine |
| 06/11/2013 | CA2581516C Quinazoline derivatives |
| 06/11/2013 | CA2572218C Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents |
| 06/11/2013 | CA2546101C N-acylsulfonamide apoptosis promoters |
| 06/11/2013 | CA2484209C Protein kinase modulators and methods of use |
| 06/11/2013 | CA2473158C Treatment of rheumatoid arthritis using imatinib |
| 06/11/2013 | CA2427334C Methods and compositions for the treatment of diseases of the eye |
| 06/06/2013 | WO2013082490A1 Substituted anilines as ccr(4) antagonists |
| 06/06/2013 | WO2013082345A1 Aryl dihydropyridinone and piperidinone as mgat2 inhibitors |
| 06/06/2013 | WO2013082102A1 Substituted 4 - phenyl - pyridines for the treatment of nk-1 receptor related diseases |
| 06/06/2013 | WO2013081783A1 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics |
| 06/06/2013 | WO2013081685A1 C-halogen bond formation |
| 06/06/2013 | WO2013081416A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 06/06/2013 | WO2013081140A1 Quinophthalone compound and pigment for color filter including said compound |
| 06/06/2013 | WO2013080036A1 Azetidine-substituted quinoxaline-type piperidine compounds and uses thereof |
| 06/06/2013 | WO2013079668A1 Piperidine derivatives, pharmaceutical compositions and uses thereof |
| 06/06/2013 | WO2013079586A1 Carboxamide-substituted heteroaryl-pyrazoles and the use thereof |
| 06/06/2013 | WO2013079505A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/06/2013 | WO2013079494A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | WO2013079460A1 Novel compounds |
| 06/06/2013 | WO2013079452A1 New bicyclic dihydroisoquinoline-1-one derivatives |
| 06/06/2013 | WO2013079425A1 Novel 2h-indazoles as ep2 receptor antagonists |
| 06/06/2013 | WO2013079350A1 Insecticidal triazinone derivatives |
| 06/06/2013 | WO2013079223A1 Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rorϒ, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases |
| 06/06/2013 | WO2013078771A1 Poly (adp-ribose) polymerase inhibitor |
| 06/06/2013 | WO2013078578A1 Lansoprazole compound and novel preparation method thereof |
| 06/06/2013 | WO2013057251A3 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 06/06/2013 | WO2013051883A3 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein |
| 06/06/2013 | WO2012074126A9 Bicyclic compound |
| 06/06/2013 | US20130144064 Microbiocidal heterocycles |
| 06/06/2013 | US20130144059 Use of pdgf-r inhibitors for the treatment of lymph node metastasis of gastric cancer |
| 06/06/2013 | US20130144056 Human Adam-10 Inhibitors |
| 06/06/2013 | US20130144054 Novel production method for isoquinoline derivatives and salts thereof |
| 06/06/2013 | US20130143931 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanomethylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as nk1 receptor antagonists |
| 06/06/2013 | US20130143929 Fungicidal imidazoles |
| 06/06/2013 | US20130143923 Crystalline forms of thalidomide and processes for their preparation |
| 06/06/2013 | US20130143922 Thio compounds |
| 06/06/2013 | US20130143914 Urea derivatives and their therapeutic use in the treatment of, inter alia, diseases of the respiratory tract |
| 06/06/2013 | US20130143906 Substituted pyrimidinone-phenyl-pyrimidinyl compounds |
| 06/06/2013 | US20130143905 Novel antagonists for ccr2 and uses thereof |
| 06/06/2013 | US20130143899 Compounds and compositions as protein kinase inhibitors |
| 06/06/2013 | US20130143893 Piperazine derivatives and methods of use |
| 06/06/2013 | US20130143883 Modulators for amyloid beta |
| 06/06/2013 | US20130143880 Positive allosteric modulators of mglur2 |
| 06/06/2013 | US20130143877 Composition comprising tetracyclic compound |
| 06/06/2013 | US20130143876 New piperidine derivatives, pharmaceutical compositions and uses thereof |
| 06/06/2013 | US20130143874 Fused ring pyridine compound |
| 06/06/2013 | US20130143871 4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors |